0000914190-21-000206.txt : 20210804 0000914190-21-000206.hdr.sgml : 20210804 20210804161031 ACCESSION NUMBER: 0000914190-21-000206 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210802 FILED AS OF DATE: 20210804 DATE AS OF CHANGE: 20210804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDSTEIN ALLAN L CENTRAL INDEX KEY: 0000905390 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15070 FILM NUMBER: 211144093 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0000707511 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521253406 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15245 SHADY GROVE ROAD STREET 2: SUITE 470 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-208-9191 MAIL ADDRESS: STREET 1: 15245 SHADY GROVE ROAD STREET 2: SUITE 470 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: ALPHA 1 BIOMEDICALS INC DATE OF NAME CHANGE: 19950719 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2021-08-02 0000707511 REGENERX BIOPHARMACEUTICALS INC RGRX 0000905390 GOLDSTEIN ALLAN L C/O REGENERX BIOPHARMACEUTICALS, INC. 15245 SHADY GROVE ROAD, SUITE 470 ROCKVILLE MD 20850 1 0 0 0 Common Stock 1637793 D Stock Option (right to buy) 0.36 2022-06-30 Common Stock 250000 250000 D Stock Option (right to buy) 0.64 2023-03-16 Common Stock 200000 200000 D Stock Option (right to buy) 0.28 2027-09-01 Common Stock 150000 150000 D Stock Option (right to buy) 0.21 2028-07-17 Common Stock 250000 250000 D Stock Option (right to buy) 0.21 2029-05-15 Common Stock 410000 410000 D Stock Option (right to buy) 0.30 2030-06-10 Common Stock 400000 400000 D Convertible Promissory Note (right to buy) 0.12 2019-02-27 2024-02-27 Common Stock 20833 2500.00 D Convertible Promissory Note (right to buy) 0.12 2019-05-13 2024-05-13 Common Stock 20833 2500.00 D Convertible Promissory Note (right to buy) 0.36 2020-10-15 2025-10-15 Common Stock 13920 5000 D Common Stock Warrant (right to buy) 0.18 2019-08-27 2024-02-27 Common Stock 15625 15625 D Common Stock Warrant (right to buy) 0.18 2019-11-13 2024-05-13 Common Stock 15625 15625 D Common Stock Warrant (right to buy) 0.45 2021-04-15 2025-10-15 Common Stock 10440 10440 D Series A Common Stock Warrant (right to buy) 0.24 2021-06-30 2023-06-30 Common Stock 93750 93750 D Series B Common Stock Warrant (right to buy) 0.28 2021-06-30 2026-06-30 Common Stock 93750 93750 D Stock Option (right to buy) 0.28 2021-08-02 4 A 0 480000 0 A 2031-08-02 Common Stock 480000 480000 D 100% vested. 102,500 shares vest on each of 5/15/19, 5/15/20, 5/15/21 and 5/15/22. 100,000 shares vest on each of 6/10/20, 6/10/21, 6/10/22 and 6/10/23. 120,000 shares vest on each of 8/2/21, 8/2/22, 8/2/23 and 8/2/24. /s/ Andrew Nick as Attorney-in-Fact for Allan Goldstein, Ph.D. pursuant to Power of Attorney previously filed. 2021-08-04